| Rohit Pawar, MD | |
|
10018 Kennerly Rd, Saint Louis, MO 63128-2106 | |
| (314) 525-7275 | |
| (314) 525-7260 |
| Full Name | Rohit Pawar |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 23 Years |
| Location | 10018 Kennerly Rd, Saint Louis, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013237122 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Anthonys Physician Organization Hospitalist Services Lc | 5092980656 | 87 |
News Archive
To infect its host, the respiratory pathogen Pseudomonas aeruginosa takes an ordinary protein usually involved in making other proteins and adds three small molecules to turn it into a key for gaining access to human cells.
Omega Healthcare Investors, Inc., announced today that its Board of Directors has authorized the repurchase of up to $100 million of its outstanding common stock, from time to time over the next 12 months.
Mayo Clinic researchers have identified an immune system deficiency whose presence shows someone is up to four times likelier to die than a person without it. The glitch involves an antibody molecule called a free light chain; people whose immune systems produce too much of the molecule are far more likely to die of a life-threatening illness such as cancer, diabetes and cardiac and respiratory disease than those whose bodies make normal levels. The study is published in the June issue of Mayo Clinic Proceedings.
An immune system messenger molecule that normally helps quiet inflammation could be an effective tool against multiple sclerosis (MS). Neurology researchers led by Abdolmohamad Rostami, M.D., Ph.D., professor and chair of the Department of Neurology at Jefferson Medical College of Thomas Jefferson University and the Jefferson Hospital for Neuroscience in Philadelphia, have found that the protein interkeukin-27 (IL-27) helped block the onset or reverse symptoms in animals with an MS-like disease.
› Verified 7 days ago
| Entity Name | Mercy Clinic Adult Hospitalists - St. Louis, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841235108 PECOS PAC ID: 6002809944 Enrollment ID: O20040406001004 |
News Archive
To infect its host, the respiratory pathogen Pseudomonas aeruginosa takes an ordinary protein usually involved in making other proteins and adds three small molecules to turn it into a key for gaining access to human cells.
Omega Healthcare Investors, Inc., announced today that its Board of Directors has authorized the repurchase of up to $100 million of its outstanding common stock, from time to time over the next 12 months.
Mayo Clinic researchers have identified an immune system deficiency whose presence shows someone is up to four times likelier to die than a person without it. The glitch involves an antibody molecule called a free light chain; people whose immune systems produce too much of the molecule are far more likely to die of a life-threatening illness such as cancer, diabetes and cardiac and respiratory disease than those whose bodies make normal levels. The study is published in the June issue of Mayo Clinic Proceedings.
An immune system messenger molecule that normally helps quiet inflammation could be an effective tool against multiple sclerosis (MS). Neurology researchers led by Abdolmohamad Rostami, M.D., Ph.D., professor and chair of the Department of Neurology at Jefferson Medical College of Thomas Jefferson University and the Jefferson Hospital for Neuroscience in Philadelphia, have found that the protein interkeukin-27 (IL-27) helped block the onset or reverse symptoms in animals with an MS-like disease.
› Verified 7 days ago
| Entity Name | Mercy Clinic Adult Hospitalists - Washington, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891943429 PECOS PAC ID: 3577630540 Enrollment ID: O20080917000782 |
News Archive
To infect its host, the respiratory pathogen Pseudomonas aeruginosa takes an ordinary protein usually involved in making other proteins and adds three small molecules to turn it into a key for gaining access to human cells.
Omega Healthcare Investors, Inc., announced today that its Board of Directors has authorized the repurchase of up to $100 million of its outstanding common stock, from time to time over the next 12 months.
Mayo Clinic researchers have identified an immune system deficiency whose presence shows someone is up to four times likelier to die than a person without it. The glitch involves an antibody molecule called a free light chain; people whose immune systems produce too much of the molecule are far more likely to die of a life-threatening illness such as cancer, diabetes and cardiac and respiratory disease than those whose bodies make normal levels. The study is published in the June issue of Mayo Clinic Proceedings.
An immune system messenger molecule that normally helps quiet inflammation could be an effective tool against multiple sclerosis (MS). Neurology researchers led by Abdolmohamad Rostami, M.D., Ph.D., professor and chair of the Department of Neurology at Jefferson Medical College of Thomas Jefferson University and the Jefferson Hospital for Neuroscience in Philadelphia, have found that the protein interkeukin-27 (IL-27) helped block the onset or reverse symptoms in animals with an MS-like disease.
› Verified 7 days ago
| Entity Name | St Anthonys Physician Organization Hospitalist Services Lc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407216336 PECOS PAC ID: 5092980656 Enrollment ID: O20111208000771 |
News Archive
To infect its host, the respiratory pathogen Pseudomonas aeruginosa takes an ordinary protein usually involved in making other proteins and adds three small molecules to turn it into a key for gaining access to human cells.
Omega Healthcare Investors, Inc., announced today that its Board of Directors has authorized the repurchase of up to $100 million of its outstanding common stock, from time to time over the next 12 months.
Mayo Clinic researchers have identified an immune system deficiency whose presence shows someone is up to four times likelier to die than a person without it. The glitch involves an antibody molecule called a free light chain; people whose immune systems produce too much of the molecule are far more likely to die of a life-threatening illness such as cancer, diabetes and cardiac and respiratory disease than those whose bodies make normal levels. The study is published in the June issue of Mayo Clinic Proceedings.
An immune system messenger molecule that normally helps quiet inflammation could be an effective tool against multiple sclerosis (MS). Neurology researchers led by Abdolmohamad Rostami, M.D., Ph.D., professor and chair of the Department of Neurology at Jefferson Medical College of Thomas Jefferson University and the Jefferson Hospital for Neuroscience in Philadelphia, have found that the protein interkeukin-27 (IL-27) helped block the onset or reverse symptoms in animals with an MS-like disease.
› Verified 7 days ago
| Entity Name | Mercy East Support Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225382013 PECOS PAC ID: 0446498729 Enrollment ID: O20130528000281 |
News Archive
To infect its host, the respiratory pathogen Pseudomonas aeruginosa takes an ordinary protein usually involved in making other proteins and adds three small molecules to turn it into a key for gaining access to human cells.
Omega Healthcare Investors, Inc., announced today that its Board of Directors has authorized the repurchase of up to $100 million of its outstanding common stock, from time to time over the next 12 months.
Mayo Clinic researchers have identified an immune system deficiency whose presence shows someone is up to four times likelier to die than a person without it. The glitch involves an antibody molecule called a free light chain; people whose immune systems produce too much of the molecule are far more likely to die of a life-threatening illness such as cancer, diabetes and cardiac and respiratory disease than those whose bodies make normal levels. The study is published in the June issue of Mayo Clinic Proceedings.
An immune system messenger molecule that normally helps quiet inflammation could be an effective tool against multiple sclerosis (MS). Neurology researchers led by Abdolmohamad Rostami, M.D., Ph.D., professor and chair of the Department of Neurology at Jefferson Medical College of Thomas Jefferson University and the Jefferson Hospital for Neuroscience in Philadelphia, have found that the protein interkeukin-27 (IL-27) helped block the onset or reverse symptoms in animals with an MS-like disease.
› Verified 7 days ago
| Entity Name | Mercy Clinic Adult Hospitalists Jefferson Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083052492 PECOS PAC ID: 8628205598 Enrollment ID: O20131220001798 |
News Archive
To infect its host, the respiratory pathogen Pseudomonas aeruginosa takes an ordinary protein usually involved in making other proteins and adds three small molecules to turn it into a key for gaining access to human cells.
Omega Healthcare Investors, Inc., announced today that its Board of Directors has authorized the repurchase of up to $100 million of its outstanding common stock, from time to time over the next 12 months.
Mayo Clinic researchers have identified an immune system deficiency whose presence shows someone is up to four times likelier to die than a person without it. The glitch involves an antibody molecule called a free light chain; people whose immune systems produce too much of the molecule are far more likely to die of a life-threatening illness such as cancer, diabetes and cardiac and respiratory disease than those whose bodies make normal levels. The study is published in the June issue of Mayo Clinic Proceedings.
An immune system messenger molecule that normally helps quiet inflammation could be an effective tool against multiple sclerosis (MS). Neurology researchers led by Abdolmohamad Rostami, M.D., Ph.D., professor and chair of the Department of Neurology at Jefferson Medical College of Thomas Jefferson University and the Jefferson Hospital for Neuroscience in Philadelphia, have found that the protein interkeukin-27 (IL-27) helped block the onset or reverse symptoms in animals with an MS-like disease.
› Verified 7 days ago
| Entity Name | Ssm Health Care Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306589544 PECOS PAC ID: 0143608372 Enrollment ID: O20220531002655 |
News Archive
To infect its host, the respiratory pathogen Pseudomonas aeruginosa takes an ordinary protein usually involved in making other proteins and adds three small molecules to turn it into a key for gaining access to human cells.
Omega Healthcare Investors, Inc., announced today that its Board of Directors has authorized the repurchase of up to $100 million of its outstanding common stock, from time to time over the next 12 months.
Mayo Clinic researchers have identified an immune system deficiency whose presence shows someone is up to four times likelier to die than a person without it. The glitch involves an antibody molecule called a free light chain; people whose immune systems produce too much of the molecule are far more likely to die of a life-threatening illness such as cancer, diabetes and cardiac and respiratory disease than those whose bodies make normal levels. The study is published in the June issue of Mayo Clinic Proceedings.
An immune system messenger molecule that normally helps quiet inflammation could be an effective tool against multiple sclerosis (MS). Neurology researchers led by Abdolmohamad Rostami, M.D., Ph.D., professor and chair of the Department of Neurology at Jefferson Medical College of Thomas Jefferson University and the Jefferson Hospital for Neuroscience in Philadelphia, have found that the protein interkeukin-27 (IL-27) helped block the onset or reverse symptoms in animals with an MS-like disease.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rohit Pawar, MD 10018 Kennerly Rd, Saint Louis, MO 63128-2106 Ph: (314) 525-7275 | Rohit Pawar, MD 10018 Kennerly Rd, Saint Louis, MO 63128-2106 Ph: (314) 525-7275 |
News Archive
To infect its host, the respiratory pathogen Pseudomonas aeruginosa takes an ordinary protein usually involved in making other proteins and adds three small molecules to turn it into a key for gaining access to human cells.
Omega Healthcare Investors, Inc., announced today that its Board of Directors has authorized the repurchase of up to $100 million of its outstanding common stock, from time to time over the next 12 months.
Mayo Clinic researchers have identified an immune system deficiency whose presence shows someone is up to four times likelier to die than a person without it. The glitch involves an antibody molecule called a free light chain; people whose immune systems produce too much of the molecule are far more likely to die of a life-threatening illness such as cancer, diabetes and cardiac and respiratory disease than those whose bodies make normal levels. The study is published in the June issue of Mayo Clinic Proceedings.
An immune system messenger molecule that normally helps quiet inflammation could be an effective tool against multiple sclerosis (MS). Neurology researchers led by Abdolmohamad Rostami, M.D., Ph.D., professor and chair of the Department of Neurology at Jefferson Medical College of Thomas Jefferson University and the Jefferson Hospital for Neuroscience in Philadelphia, have found that the protein interkeukin-27 (IL-27) helped block the onset or reverse symptoms in animals with an MS-like disease.
› Verified 7 days ago
Dr. Lauren Flynn, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 231 W Lockwood Ave, Suite 202, Saint Louis, MO 63119 Phone: 314-737-4070 | |
Ryan Bradley Sondergard, D.O. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 10018 Kennerly Rd, Saint Louis, MO 63128 Phone: 314-525-4429 | |
Dr. Antonina S Gesmundo, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1 Jefferson Barracks Dr, Saint Louis, MO 63125 Phone: 314-894-6636 | |
Mr. Robert Harry Brady, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1430 Olive St, Suite 500, Saint Louis, MO 63103 Phone: 314-206-3724 Fax: 314-206-3708 | |
Dr. Marcus E Raichle, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 517 S Euclid Ave, Ground Floor, Saint Louis, MO 63110 Phone: 314-362-6907 Fax: 314-747-3258 | |
Dr. Rushaniya Albeptovna Khairova, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 24 S Kingshighway Blvd, Saint Louis, MO 63108 Phone: 314-286-1700 Fax: 314-286-1730 |